05.10.2012
- The Federal Trade Commission asked the US Supreme Court on Thursday to take up its fight against deals between brand-name drug companies and generic firms which they say delay the...
03.10.2012
- Drugmakers Sanofi and Bristol-Myers Squibb plan to revamp their 15-year-old alliance from Jan. 1 in response to lost exclusivity on two key drugs and the arrival of generic...
02.10.2012
- U.S. antitrust regulators found no wrongdoing in a deal made four years ago between German drugmaker Bayer and a division of Teva Pharmaceuticals to end patent litigation over the...
25.09.2012
- Market Transition - When we think about the patent cliff, an image along the lines of a massive waterfall, with companies' revenues in free fall comes to mind. What we usually...
20.09.2012
- Pressure from governments to lower drug prices risks undermining medical innovation, Bayer's chief executive Marjin Dekkers said on Wednesday, echoing complaints of other drug...
30.08.2012
- U.S. drug regulators gave the nod to a Teva Pharmaceutical Industries drug that boosts the production of infection-fighting white blood cells in certain cancer patients receiving...
20.08.2012
- India's highest court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the country's healthcare sector and...
04.08.2012
- A divided federal appeals court overturned an order in favor of Momenta Pharmaceuticals that had blocked Watson Pharmaceuticals from selling a generic version of the blood-thinning...
